IQVIA™ has announced the launch of the IQVIA Patient Portal, a global web-based solution built on a leading health cloud platform. This innovative tool enables increases in clinical trial patient recruitment, engagement and retention by ensuring transparency and collaboration before, during, and after a clinical study.
“Patient communities are clear about what matters most to them, roughly 90 percent want access to information about their participation in the study including updates about the outcome of a study,” said Cynthia Verst, president, Design and Delivery Innovation, Research & Development Solutions at IQVIA. “IQVIA’s Patient Portal increases patient understanding and engagement during the trial and reduces the substantial cost associated with patients dropping out of a trial or being unavailable for follow-up.”
Trial participants are invited to join the IQVIA Patient Portal when they are recruited. Upon enrollment, they are guided through the trial process with study visit and medication reminders, disease education, and concierge and travel support services. In addition, they are provided access to the individual lab results from their participation and other general information relating to the study as approved by the sponsor and investigator. Upon trial completion, patients receive a plain language summary of the study. Additionally, patients can join an alumni community where they can continue to engage with clinical research through future trial participation opportunities.
IQVIA’s geographic scale and expertise address the regulatory and compliance needs of customers regardless of where the study takes place, and retention solutions are built specifically for each clinical trial location with relevant study-level content.
The IQVIA Patient Portal is part of IQVIA’s full-service clinical trial offering or as a stand-alone solution. For more information about the IQVIA Patient Portal, visit www.iqvia.com.